Development of a HPLC Method for the Determination of Cyclosporine A From Chitosan Nanoparticles
dc.authorid | KAYNAK, Mustafa Sinan/0000-0003-2917-2407 | |
dc.authorid | Buyuktuncel, Ebru/0000-0001-7269-6594 | |
dc.authorwosid | Aktaş, Yeşim/ABB-3264-2020 | |
dc.authorwosid | Buyuktuncel, Saliha Ebru/ABH-9343-2020 | |
dc.authorwosid | KAYNAK, Mustafa Sinan/D-9453-2019 | |
dc.authorwosid | Yücel, Çiğdem/AAT-6484-2021 | |
dc.contributor.author | Buyuktuncel, Ebru | |
dc.contributor.author | Yucel, Cigdem | |
dc.contributor.author | Kaynak, M. Sinan | |
dc.contributor.author | Aktas, Yesim | |
dc.date.accessioned | 2024-08-04T20:36:12Z | |
dc.date.available | 2024-08-04T20:36:12Z | |
dc.date.issued | 2012 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | A reversed-phase high performance liquid chromatographic method was developed for the determination of cyclosporine A from chitosan nanoparticles. Ibuprofen was used as internal standard. The separation was achieved on a Phenomenex C18 column (150 x 4.6mm, 5 mu m) using 60: 20: 20, acetonitril: methanol: water mixture at pH 4 as mobile phase under isocratic conditions. The system was operated at 80 degrees C and the flow rate of mobile phase was adjusted to 1 mL/min. The detection wavelength was set at 205 nm. The calibration curve was linear from 2 to 150 mu g/mL with correlation coefficient values from 0.9994 to 0.9997. The lower limit of quantification 2 mu g/mL and limit of detection was 0.5 mu g/mL. Recovery was 99-101 % and the intra-and inter-day coefficients of variation were 0.94-2.32 and 2.52-3.45 %, respectively depending on the concentration. The method was found to be specific, accurate, precise and sensitive for the determination of cyclosporine A from chitosan based drug delivery systems. | en_US |
dc.description.sponsorship | Erciyes University Research Council [TSA-11-3472] | en_US |
dc.description.sponsorship | This research was supported by the Erciyes University Research Council (Project no: TSA-11-3472). | en_US |
dc.identifier.endpage | 1088 | en_US |
dc.identifier.issn | 0326-2383 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.scopus | 2-s2.0-84869169339 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 1083 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/95855 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000208861000001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Colegio Farmaceuticos Provincia De Buenos Aires | en_US |
dc.relation.ispartof | Latin American Journal of Pharmacy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chitosan nanoparticles | en_US |
dc.subject | Cyclosporine A | en_US |
dc.subject | HPLC | en_US |
dc.title | Development of a HPLC Method for the Determination of Cyclosporine A From Chitosan Nanoparticles | en_US |
dc.type | Article | en_US |